Sinonasal mucosal melanoma treatment response assessment to immune checkpoint inhibitors using hybrid positron emission tomography imaging
© 2023. The Author(s)..
The purpose of this retrospective study was to investigate response of sinonasal mucosal melanoma (SMM) patients to treatment with immune checkpoint inhibitors (ICI), using hybrid PET imaging. Fifteen SMM patients underwent hybrid PET imaging before and three months after initiation of ICI. The disease-specific survival (DSS) was calculated. Quantitative PET parameters of the primary tumor and their association with DSS and therapy response were investigated. Nine of the fifteen (60%) patients responded to ICI therapy. Patients with therapy response depicted on hybrid PET imaging had better DSS than those without (p = 0.0058). Quantitative PET parameters of the initial PET harbored no association with DSS or therapy response. However, these findings lack of sufficient statistical power and must be interpreted with caution. The first restaging PET-imaging after ICI initiation can help stratify patients with regard to DSS.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:13 |
|---|---|
| Enthalten in: |
Scientific reports - 13(2023), 1 vom: 01. Nov., Seite 18847 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Maurer, Alexander [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
0Z5B2CJX4D |
|---|
| Anmerkungen: |
Date Completed 03.11.2023 Date Revised 08.11.2023 published: Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1038/s41598-023-45705-z |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM364066628 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM364066628 | ||
| 003 | DE-627 | ||
| 005 | 20231226211121.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1038/s41598-023-45705-z |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1213.xml |
| 035 | |a (DE-627)NLM364066628 | ||
| 035 | |a (NLM)37914764 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Maurer, Alexander |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Sinonasal mucosal melanoma treatment response assessment to immune checkpoint inhibitors using hybrid positron emission tomography imaging |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 03.11.2023 | ||
| 500 | |a Date Revised 08.11.2023 | ||
| 500 | |a published: Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2023. The Author(s). | ||
| 520 | |a The purpose of this retrospective study was to investigate response of sinonasal mucosal melanoma (SMM) patients to treatment with immune checkpoint inhibitors (ICI), using hybrid PET imaging. Fifteen SMM patients underwent hybrid PET imaging before and three months after initiation of ICI. The disease-specific survival (DSS) was calculated. Quantitative PET parameters of the primary tumor and their association with DSS and therapy response were investigated. Nine of the fifteen (60%) patients responded to ICI therapy. Patients with therapy response depicted on hybrid PET imaging had better DSS than those without (p = 0.0058). Quantitative PET parameters of the initial PET harbored no association with DSS or therapy response. However, these findings lack of sufficient statistical power and must be interpreted with caution. The first restaging PET-imaging after ICI initiation can help stratify patients with regard to DSS | ||
| 650 | 4 | |a Journal Article | |
| 650 | 7 | |a Immune Checkpoint Inhibitors |2 NLM | |
| 650 | 7 | |a Fluorodeoxyglucose F18 |2 NLM | |
| 650 | 7 | |a 0Z5B2CJX4D |2 NLM | |
| 700 | 1 | |a Gstrein, Nathalie A |e verfasserin |4 aut | |
| 700 | 1 | |a Dimitriou, Florentia |e verfasserin |4 aut | |
| 700 | 1 | |a Sartoretti, Thomas |e verfasserin |4 aut | |
| 700 | 1 | |a Schaab, Jan A |e verfasserin |4 aut | |
| 700 | 1 | |a Looman, Esmée L |e verfasserin |4 aut | |
| 700 | 1 | |a Balermpas, Panagiotis |e verfasserin |4 aut | |
| 700 | 1 | |a Rupp, Niels J |e verfasserin |4 aut | |
| 700 | 1 | |a Freiberger, Sandra N |e verfasserin |4 aut | |
| 700 | 1 | |a Soyka, Michael B |e verfasserin |4 aut | |
| 700 | 1 | |a Holzmann, David |e verfasserin |4 aut | |
| 700 | 1 | |a Mauthe, Tina |e verfasserin |4 aut | |
| 700 | 1 | |a Mueller, Simon A |e verfasserin |4 aut | |
| 700 | 1 | |a Beintner-Skawran, Stephan |e verfasserin |4 aut | |
| 700 | 1 | |a Messerli, Michael |e verfasserin |4 aut | |
| 700 | 1 | |a Kenkel, David |e verfasserin |4 aut | |
| 700 | 1 | |a Huellner, Martin W |e verfasserin |4 aut | |
| 700 | 1 | |a Meerwein, Christian M |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Scientific reports |d 2011 |g 13(2023), 1 vom: 01. Nov., Seite 18847 |w (DE-627)NLM215703936 |x 2045-2322 |7 nnns |
| 773 | 1 | 8 | |g volume:13 |g year:2023 |g number:1 |g day:01 |g month:11 |g pages:18847 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1038/s41598-023-45705-z |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 13 |j 2023 |e 1 |b 01 |c 11 |h 18847 | ||